CVE:IOT Innovotech (IOT) Stock Price, News & Analysis C$0.30 +0.03 (+11.32%) As of 03:38 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesInsider TradesBuy This Stock About Innovotech Stock (CVE:IOT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Innovotech alerts:Sign Up Key Stats Today's RangeC$0.28▼C$0.3050-Day RangeC$0.19▼C$0.3052-Week RangeC$0.10▼C$0.31Volume54,500 shsAverage Volume58,023 shsMarket CapitalizationC$11.51 millionP/E RatioN/ADividend Yield10.00%Price TargetN/AConsensus RatingN/A Company Overview Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada. Read More Receive IOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovotech and its competitors with MarketBeat's FREE daily newsletter. Email Address IOT Stock News HeadlinesInnovotech With President, Director & CEO Craig MilneMay 23, 2025 | msn.comPublic market insider buying at Innovotech (IOT)May 20, 2025 | theglobeandmail.comThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.July 25 at 2:00 AM | Paradigm Press (Ad)Innovotech Secures Funding to Advance Antimicrobial Testing and Product DevelopmentMay 8, 2025 | tipranks.comInnovotech Achieves Record Annual Revenue and Positive Net Income for 2024April 18, 2025 | seekingalpha.comAre Innovotech Inc.'s (CVE:IOT) Mixed Financials Driving The Negative Sentiment?April 17, 2025 | finance.yahoo.comInnovotech Reports Record Revenue and Profit for 2024April 16, 2025 | tipranks.comSeveral Insiders Invested In Innovotech Flagging Positive NewsFebruary 6, 2025 | finance.yahoo.comSee More Headlines IOT Stock Analysis - Frequently Asked Questions How have IOT shares performed this year? Innovotech's stock was trading at C$0.18 at the start of the year. Since then, IOT shares have increased by 63.9% and is now trading at C$0.30. How do I buy shares of Innovotech? Shares of IOT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Innovotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Innovotech investors own include Absolute Software (ABST), Ford Motor (F), Agiliti (AGTI), PlayAGS (AGS), Ares Capital (ARCC), Century Bancorp (CNBKA) and Chevron (CVX). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryComputer Software Current SymbolCVE:IOT CIKN/A Webwww.incomeopp-realty.com Phone+1-780-4480585FaxN/AEmployees1,620Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net Margins-29.67% Pretax MarginN/A Return on Equity-39.52% Return on Assets-33.01% Debt Debt-to-Equity Ratio12.55 Current Ratio2.63 Quick Ratio5.81 Sales & Book Value Annual SalesC$1.23 million Price / Sales9.35 Cash FlowC$0.03 per share Price / Cash Flow10.71 Book ValueC$0.02 per share Price / Book14.75Miscellaneous Outstanding Shares39,000,000Free FloatN/AMarket CapC$11.51 million OptionableNot Optionable Beta1.15 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (CVE:IOT) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.